BioSpace News Archive

Pharm Country

Gotham Therapeutics and Mercachem Announce Progress in Compound Library Development Tailored for Epitranscriptomic Drug Discovery

Research led to a collection of over 2,000 analogues and over 80 distinct chemotypes displaying an up to 1,000-fold increased affinity to epitranscriptomic targets.

July 17, 2019
·
3 min read
Deals

Orum Therapeutics Announces $30 Million Series B Financing to Advance Cell-Penetrating, Cell-Specific Antibody Technology for Novel Therapeutics

Financing proceeds to fund further platform development and therapeutic discovery in cancer and rare diseases, and expansion of Orum’s new Boston R&D labs

July 17, 2019
·
2 min read
FDA

Q’Apel Medical Announces FDA Clearance for Walrus Balloon Guide Catheter

Q’Apel Medical announced that it received U.S. Food and Drug Administration clearance for its novel walrus Balloon Guide Catheter.

July 17, 2019
·
1 min read
Drug Development

PureTech Acquires New Clinical-Stage Program LYT-100 to Treat Lymphedema

Wholly owned program adds to Company’s growing internal pipeline focused on lymphatic targeting and tissue-selective immunomodulation

July 17, 2019
·
6 min read
Deals

Sobi Publishes Report for Second Quarter 2019

Swedish Orphan Biovitrum AB announces its results for the second quarter 2019.

July 17, 2019
·
5 min read
Deals

Getinge Publishes Interim Report for January - June 2019

Getinge is reporting an increase in organic sales by 4.0% and an increased order intake of 5.2% organically, which means that Getinge’s growth remains higher than the market average.

July 17, 2019
·
3 min read
Business

Astellas and Frequency Therapeutics Enter into License Agreement for FX-322, a Regenerative Treatment Candidate for Hearing Loss

Astellas Obtains the Exclusive Rights to Develop and Commercialize FX-322 in Ex-U.S. Markets; Frequency Retains U.S. Rights

July 17, 2019
·
5 min read
Oblique Therapeutics has been Recognized as one of the 15 Most Promising Biotech Startups in Europe 2019, by StartUp City Magazine

Oblique Therapeutics, a Swedish biotech focusing on generating novel therapeutic antibodies towards severe diseases such as cancer and pain, has been honored as one of the most promising biotech startup in Europe 2019 by StartUp City magazine.

July 17, 2019
·
2 min read
Job Trends

GB Sciences Files Novel Patent Application For Chronic Pain Treatments Based On Proprietary Cannabis-Derived Formulations

In the US, chronic pain represents an estimated health burden of between $560 and $650 billion dollars.

July 17, 2019
·
5 min read
BioMidwest

Exact Sciences Designated a Great Place to Work-Certified™ Company in 2019

Hundreds of open positions offer opportunity to join growing company

July 17, 2019
·
7 min read